The RESCUE study is a combined retrospective and prospective multicentre cohort study investigating the survival and functional outcomes in patients undergoing salvage surgery for recurrent, residual, and new primary head and neck squamous cell carcinoma (SCC). Additionally, the RESCUE study will contain an exploratory molecular analysis of consenting patients to assess the relationship between cancer genomics, previous radiotherapy, and recurrence in head and neck cancer.
The RESCUE study is a combined retrospective and prospective multicentre cohort study investigating the survival and functional outcomes in patients undergoing salvage surgery for recurrent, residual, and new primary head and neck squamous cell carcinoma (SCC). Additionally, the RESCUE study will contain an exploratory molecular analysis of consenting patients to assess the relationship between cancer genomics, previous radiotherapy, and recurrence in head and neck cancer. The aim of this study is to determine the survival, functional and quality of life outcomes of patients undergoing all salvage surgery for recurrent, residual and new primary head and neck SCC, and to establish the genetic architecture and clonal evolution H\&N SCC after previous treatment for radiotherapy cancer.
Study Type
OBSERVATIONAL
Enrollment
400
Nucleic acid extraction, protein analysis. Tumour tissue, blood and saliva samples collected.
University Hospitals Derby and Burton
Derby, United Kingdom
RECRUITINGNHS Lothian
Edinburgh, United Kingdom
RECRUITINGWestern General, Greater Glasgow and Clyde
Glasgow, United Kingdom
RECRUITINGAintree Hospital
Liverpool, United Kingdom
RECRUITINGHead and Neck Unit, Royal Marsden Hospital
London, United Kingdom
RECRUITINGNorthwick Park
London, United Kingdom
RECRUITINGOxford University Hospital NHS Foundation Trust
Oxford, United Kingdom
RECRUITINGPoole Hospital, University Hospitals Dorset
Poole, United Kingdom
RECRUITINGSouth Tyneside and Sunderland NHS Foundation Trust
Sunderland, United Kingdom
COMPLETEDAscertain the 2-year disease-free survival post salvage surgery
Ascertain the 2-year disease-free survival post salvage surgery for recurrent/ residual/ new primary head and neck SCC (split cohort of prospective and retrospective patients)
Time frame: Study duration is 3 years to include 1 year recruitment period. Active follow-up for patients is up to 2 years.
Define the 2- and 5-year overall and disease specific survival in retrospectively identified patients
Define the 2- and 5-year overall and disease specific survival in retrospectively identified patients undergoing salvage surgery for recurrent/ residual/ new primary head and neck SCC
Time frame: Study duration is 3 years to include 1 year recruitment period. Active follow-up for prospective patients is up to 2 years. Follow-up for retrospective patients is up to 5 years.
Define the 2 year overall and disease specific survival in prospectively identified patients
Define the 2 year overall and disease specific survival in prospectively identified patients undergoing salvage surgery for recurrent/ residual/ new primary head and neck SCC
Time frame: Study duration is 3 years to include 1 year recruitment period. Active follow-up for patients is up to 2 years.
Report on gross functional outcomes by documenting rates of gastrostomy and tracheostomy dependence at 1-year post-salvage surgery.
Report on gross functional outcomes by documenting rates of gastrostomy and tracheostomy dependence at 1-year post-salvage surgery.
Time frame: Study duration is 3 years with up to 2 years follow-up in prospective and up to 5 years follow-up in retrospective patients. Functional outcomes will be measured from the date of surgery.
For the prospective cohort assess the overall quality-of-life outcomes pre-operatively and at 6- and 12-months post-surgery using validated questionnaires.
For the prospective cohort assess the overall quality-of-life outcomes at pre-operatively and at 6- and 12-months post-surgery using validated University of Washington Quality of Life questionnaire.
Time frame: University of Washing Quality of life questionnaire distributed pre-operatively, 6 months and 12 months.
For the prospective cohort assess the swallow-related quality-of-life outcomes at pre-operatively and at 6- and 12-months post-surgery using validated questionnaires.
For the prospective cohort assess the swallow-related quality-of-life outcomes pre-operatively and at 6- and 12-months post-surgery using validated questionnaires.
Time frame: MD Anderson Dysphagia Inventory distributed pre-operatively, 6 months and 12 months.
Estimate the rates of close and involved surgical margins across all surgical salvage procedures
Estimate the rates of close and involved surgical margins across all surgical salvage procedures
Time frame: Through study completion, expected duration of 3 years
Determine the impact of close and involved margins on overall survival outcomes
Determine the impact of close and involved margins on overall survival outcomes
Time frame: Through study completion, expected duration of 3 years
Determine the impact of close and involved margins on disease-free survival outcomes
Determine the impact of close and involved margins on disease-free survival outcomes
Time frame: Through study completion, expected duration of 3 years
Determine the impact of close and involved margins on disease-specific survival outcomes
Determine the impact of close and involved margins on disease-specific survival outcomes
Time frame: Through study completion, expected duration of 3 years
Establish the rates of super-selective, selective and modified/ radical salvage neck dissection in clinically N0 and N+ necks
Establish the rates of super-selective, selective and modified/ radical salvage neck dissection in clinically N0 and N+ necks
Time frame: Through study completion, expected duration of 3 years
Ascertain how the extent of salvage neck dissection influences overall survival outcomes.
Ascertain how the extent of salvage neck dissection influences overall survival outcomes.
Time frame: Through study completion, expected duration of 3 years
Ascertain how the extent of salvage neck dissection influences disease-free survival outcomes.
Ascertain how the extent of salvage neck dissection influences disease-free survival outcomes.
Time frame: Through study completion, expected duration of 3 years
Ascertain how the extent of salvage neck dissection influences disease-specific survival outcomes.
Ascertain how the extent of salvage neck dissection influences disease-specific survival outcomes.
Time frame: Through study completion, expected duration of 3 years
Estimate the rate of occult nodal metastasis in clinically N0 necks with locally recurrent disease
Estimate the rate of occult nodal metastasis in clinically N0 necks with locally recurrent disease
Time frame: Through study completion, expected duration of 3 years
Describe the impact of neck dissection on overall survival outcomes in patients with clinically N0 necks with and without subsequent occult nodal disease
Describe the impact of neck dissection on overall survival outcomes in patients with clinically N0 necks with and without subsequent occult nodal disease
Time frame: Through study completion, expected duration of 3 years
Describe the impact of neck dissection on disease-free survival outcomes in patients with clinically N0 necks with and without subsequent occult nodal disease
Describe the impact of neck dissection on disease-free survival outcomes in patients with clinically N0 necks with and without subsequent occult nodal disease
Time frame: Through study completion, expected duration of 3 years
Describe the impact of neck dissection on disease-specific survival outcomes in patients with clinically N0 necks with and without subsequent occult nodal disease
Describe the impact of neck dissection on disease-specific survival outcomes in patients with clinically N0 necks with and without subsequent occult nodal disease
Time frame: Through study completion, expected duration of 3 years
Using multi-variate analysis, establish the clinical prognostic indicators of overall, disease free and disease specific survival.
Establish the clinical prognostic indicators of positive survival and functional outcomes
Time frame: Through study completion, expected duration of 3 years
Using multi-variate analysis, establish the clinical prognostic indicators 12 month tracheostomy and gastrostomy dependence.
Establish the clinical prognostic indicators of functional outcomes
Time frame: Through study completion, expected duration of 3 years
Compare the DNA genetic and epigenetic changes in residual, recurrent, and new primary head and neck squamous cell carcinoma with primary tumour and germline DNA samples.
Assess the molecular makeup of head and neck tumours that have not responded to radiotherapy treatment, or which recur having previously responded.
Time frame: Through study completion, expected duration of 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.